As a vital immunoregulatory cytokine, IL‐6 mediates chemoresistance through various signaling pathways (Figure 1), with the JAK2/STAT3 signaling pathway being particularly prominent in ovarian cancer.27 Here, JAK2 is linked to ovarian carcinoma.